The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.

Autor: Dravillas CE; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Coleman SS 4th; Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Hoyd R; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Caryotakis G; Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Denko L; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Chan CHF; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa., Churchman ML; Aster Insights, Hudson, Florida., Denko N; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Dodd RD; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Eljilany I; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Hardikar S; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Husain M; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Ikeguchi AP; Department of Hematology/Oncology, Stephenson Cancer Center of University of Oklahoma, Oklahoma City, Oklahoma., Jin N; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Ma Q; Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio., McCarter MD; Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado., Osman AEG; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, Utah., Robinson LA; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Singer EA; Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Tinoco G; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Ulrich CM; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Zakharia Y; Division of Oncology, Hematology and Blood and Marrow Transplantation, University of Iowa, Holden Comprehensive Cancer Center, Iowa City, Iowa., Spakowicz D; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Tarhini AA; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Tan AC; Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 1978-1990.

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset.

Autor: Wang C; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA., Ma A; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA., McNutt ME; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA., Hoyd R; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Wheeler CE; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Robinson LA; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan CHF; University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA., Zakharia Y; Division of Oncology, Hematology and Blood & Marrow Transplantation, University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA., Dodd RD; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Ulrich CM; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Hardikar S; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Churchman ML; Clinical & Life Sciences, M2GEN, Tampa, FL, USA., Tarhini AA; Departments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Singer EA; Department of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Ikeguchi AP; Department of Hematology/Oncology, Stephenson Cancer Center of University of Oklahoma, Oklahoma City, OK, USA., McCarter MD; Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA., Denko N; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Tinoco G; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Husain M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Jin N; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Osman AEG; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA., Eljilany I; Clinical Science Lab -- Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Tan AC; Departments of Oncological Science and Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Coleman SS 4th; Departments of Oncological Science and Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Denko L; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Riedlinger G; Department of Precision Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Schneider BP; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, USA., Spakowicz D; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Ma Q; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 May 24. Date of Electronic Publication: 2023 May 24.